Sign up UNITED KINGDOM
Proactive Investors - Run By Investors For Investors

OptiBiotix Health plc RNS Release

Investor evening


RNS Number : 9507P
OptiBiotix Health PLC
06 September 2017
 

Opti B i otix Health plc

( "Opti Bi o t ix"  or "the Co m pan y")

 

Investor evening

 

OptiBi otix Health  p lc (AI M : OPTI), a life sciences  busi ness  d e vel o ping products to tack le  o besit y,  high choleste r ol and  diabetes, announces that Stephen O'Hara, CEO of Optibiotix, will be presenting at an investor evening hosted by Turner Pope Investments Ltd ("TPI"). The event will be held on Tuesday 19 September 2017 in Mayfair, London and will commence at 5pm.

 

To register your interest and obtain further details, please contact TPI on  [email protected]  or call 020 3621 4121.

 

No new material or trading information will be provided.

 

 

OptiBiotix Health plc

www.optibiotix.com

Stephen O'Hara, Chief Executive

Contact via Walbrook below



Walbrook PR Ltd

Tel: 020 7933 8780 or [email protected]

Anna Dunphy

Mob: 07876 741 001

 

 

 

About OptiBiotix Health PLC - www.optibiotix.com  

OptiBiotix was formed in March 2012 to develop compounds which modify the human microbiome - the collective genome of the microbes in the body - to prevent and manage human disease.

 

The aim of OptiBiotix is to discover and develop microbial strains, compounds and formulations, which modulate the human microbiome and can be used as food ingredients and supplements or active compounds for the prevention and management of human diseases, examples of which include obesity, cholesterol and lipid distribution, diabetes, and skin health.

 

OptiBiotix has established a pipeline of microbiome modulators that can impact on lipid and cholesterol management, energy harvest, appetite suppression, and skin health. The development pipeline is fuelled by its proprietary OptiScreen® and OptiBiotic® platform technologies designed to identify metabolic pathways and compounds that impact on human physiology and bring potential health benefits. These platforms are applicable across a wider range of other human diseases.

 


This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRASSUSAMFWSESU



OptiBiotix Health plc Timeline

© Proactive Investors 2017

Proactive Investor UK Limited, trading as “Proactiveinvestors United Kingdom”, is Authorised and regulated by the Financial Conduct Authority.
Registered in England with Company Registration number 05639690. Group VAT registration number 872070825 FCA Registration number 559082. You can contact us here.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use